Q2 2013 Holdings
Filed 2013-08-14 | 24 holdings | $515.3K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ligand Pharmaceuticals Inc(LGND) | COM NEW | 53220K504 | $135.5K | 3,621,665 | 26.3% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $71.1K | 5,026,766 | 13.8% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $52.3K | 5,252,561 | 10.1% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $50.5K | 11,131,858 | 9.8% |
| Exelixis Inc | NOTE 4.250% 08/15/2019 | 30161QAC8 | $39.4K | $40,735,000 | 7.6% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $32.5K | 9,730,697 | 6.3% |
| Targacept Inc | COM | 87611R306 | $26.4K | 6,171,669 | 5.1% |
| Cytokinetics Inc | COM | 23282W100 | $19.9K | 1,718,905 | 3.9% |
| Oncothyreon Inc | COM | 682324108 | $12.6K | 8,093,278 | 2.5% |
| Array Biopharma Inc | NOTE 3.000% 06/01/2020 | 04269XAA3 | $11.4K | $12,000,000 | 2.2% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $11.4K | 2,502,256 | 2.2% |
| QLT Inc | COM | 746927102 | $10.4K | 2,370,263 | 2.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $7.5K | 305,786 | 1.5% |
| Receptos Inc | COM | 756207106 | $6.4K | 320,000 | 1.2% |
| Arqule Inc(ARQLUSD) | COM | 04269E107 | $6.1K | 2,632,432 | 1.2% |
| Pain Therapeutics Inc | COM | 69562K100 | $5.2K | 2,357,327 | 1.0% |
| Avanir Pharmaceuticals Inc | CL A NEW | 05348P401 | $4.6K | 1,006,053 | 0.9% |
| Palatin Technologies Inc | COM PAR $ .01 | 696077403 | $3.1K | 5,200,000 | 0.6% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $2.7K | 153,500 | 0.5% |
| Regulus Therapeutics Inc | COM | 75915K101 | $2.6K | 266,445 | 0.5% |
| Anthera Pharmaceuticals Inc | COM | 03674U102 | $2.1K | 4,477,000 | 0.4% |
| Flamel Technologies SA | SPONSORED ADR | 338488109 | $931 | 151,406 | 0.2% |
| Transcept Pharmaceuticals Inc | COM | 89354M106 | $453 | 150,000 | 0.1% |
| Genvec Inc | COM NEW | 37246C307 | $180 | 486,100 | 0.0% |